Elhízás: vizsgálatok itt: Spanyolország
111 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleExercise to Fight Obesity
- Where
- Valencia
- Életkor
- 18 év to 65 év
- People
- 72
- Run by
- Instituto de Investigacion Sanitaria La Fe
See details and how to joinNCT06934681 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pamplona, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- A Coruña, Badalona, Barcelona, Ferrol, Madrid, Málaga, Pozuelo de Alarcón, Sevilla
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - No phaseNot yet taking people in SpanyolországPilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
- Where
- Badalona, Calella, Mataró, Santa Coloma de Gramenet
- Életkor
- 18 év and over
- People
- 110
- Run by
- Aesculap AG
See details and how to joinNCT06547138 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- A Coruna, Madrid, Pozuelo de Alarcón, Sevilla
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- A coruña, Alcobendas, Barcelona, Centelles, Chiclana De La Frontera, Granada, Madrid, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 2001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - 3. fázisNot yet taking people in SpanyolországA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Badajoz, Barcelona, León, Madrid, Santander, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 3. fázisTaking peopleA Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Where
- A Coruña, Barcelona, Córdoba, Sabadell, Salamanca, Santiago de Compostela, Sevilla
- Életkor
- 18 év and over
- People
- 656 worldwide
- Run by
- Pfizer
See details and how to joinNCT07919678 · EU 2026-526328-34-00 - 3. fázisTaking peopleA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Where
- Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
- Életkor
- 6 év to 17 év
- People
- 125 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672549 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - No phaseTaking peopleSafety and Effectiveness of Orbera365™ Intragastric Balloon System
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT07062094 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Alzira, Barcelona, Castilleja De La Cuesta, Madrid, Málaga, Sevilla, Centro Médico Compostela
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Guadalajara, Lleida, Logroño, Madrid, Málaga, Seville
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- A Coruna, Almería, Barcelona, Castilleja De La Cuesta, Ferrol, Palma, Pozuelo de Alarcón, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisTaking peopleEfficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Where
- Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
- Életkor
- 6 év to 11 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- A Coruña, Alzira, Barcelona, Ferrol, Granada, Málaga, Seville
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 3. fázisNot yet taking people in SpanyolországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- A Coruña, Alzira, Castilleja De La Cuesta, Ferrol, Granada, Lugo, Madrid, Majadahonda, Palma, Pozuelo de Alarcón, Santander, Sevilla, Valencia
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
- Where
- A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522699-94-00 · EU 2025-522699-94-00 - No phaseCsak meghívásosChanges in Body Composition Following Pharmacological Treatment for Obesity.
- Where
- Madrid
- Életkor
- 18 év to 80 év
- People
- 116
- Run by
- Hospital San Carlos, Madrid
See details and how to joinNCT07908940 - 3. fázisNot yet taking people in SpanyolországELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
- Where
- El Palmar, Sanlúcar de Barrameda, Valencia
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Denia, El Palmar, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Lleida, Madrid, Majadahonda, Málaga, Salamanca, Valencia
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- A Coruña, Alzira (Valencia), Barcelona, Castilleja de La Cuesta, Sevilla, Ferrol (A Coruña), Lleida, Málaga, Oviedo, Segovia, Seville
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Denia, Las Palmas De Gran Canaria, L'hospitalet De Llobregat, Lleida, Madrid, Majadahonda, Málaga, Murcia, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - 3. fázisNot yet taking people in SpanyolországEfficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
- Where
- Badajoz, Barcelona, León, Málaga, Sanlúcar de Barrameda, Sevilla, Villamartín
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00